ZyVersa Therapeutics, Inc. - ZVSA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$150K
QoQ value delta ($000)
+$145K (+2900.0%)
Implied price effect (QoQ)
-37.95%
Shares
Total shares
1,172,462
QoQ shares delta
+1,148,213 (+4735.09%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ZVSA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q2 2025 data: only 6 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Walleye Capital LLC 128 980,568 0.0%
GEODE CAPITAL MANAGEMENT, LLC 16 123,130 0.0%
VANGUARD GROUP INC 2 17,194 0.0%
XTX Topco Ltd 2 16,709 0.0%
MILLENNIUM MANAGEMENT LLC 1 15,190 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1 13,537 0.0%
BANK OF AMERICA CORP /DE/ 0 100 0.0%
WELLS FARGO & COMPANY/MN 0 161 0.0%
Tower Research Capital LLC (TRC) 0 5,766 0.0%
UBS Group AG 0 107 0.0%